|
Réf :
ATS/ERS. Standards for the diagnosis and management of individuals with alpha-A
antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900
Brøgger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J 2006;27:682-8
Carrell RW, Lomas DA. Alpha1-antitrypsin deficiency - A model for
conformational diseases. N Eng Med J 2002;346:45-53
DeMeo DL, Silverman EK.
a1-antitrypsin
deficiency 2: Genetic aspects of
a1-antitrypsin
deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax
2004;59:259-64
Eden E, Mitchell
D, Mehlman B, Khouli H, Nejat M, Grieco MH, Turino GM. Atopy, asthma, and
emphysema in patients with severe alpha-1-antitrypsin deficiency. Am J
Respir Crit Care Med 1997;156:68-74
Hallberg J, Dominicus A, Eriksson UK, Gerhardsson de Verdier M, Pedersen NL,
Dahlbäck M, Nihlén U, Higenbottam T, Svartengren M. Interaction between
Smoking and Genetic Factors in the Development of Chronic Bronchitis. Am J
Respir
Crit Care Med 2008;177:486-90
Joost O, Wilk JB, Cupples A, Harmon M, Shearman AM, Baldwin CT, O’Connor GT, Myers RH, Gottlieb DJ. Genetic loci influencing lung function. A genomewide scan in the Framingham study. Am J Respir Crit Care Med 2002;165:795-9
Koyama H et al.
Genes, oxydative stress, and the risk of chronic obstructive
pulmonary disease. Thorax 1998;53(suppl 2):S10-S14
Lomas DA,Parfrey
H.
a1-antitrypsin
deficiency 4: Molecular pathophysiology. Thorax
2004;59:529-35
Luisetti M,
Seersholm N. a1-antitrypsin
deficiency 1: Epidemiology of
a1-antitrypsin
deficiency. Thorax 2004;59:164-9
McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med 2001;164:1419-24
Needham M,
Stockley RA.
a1-antitrypsin
deficiency 3: Clinical manifestations and natural history. Thorax
2004;59:441-5
Piitulainen E,
Sveger T. Respiratory symptoms and lung function in young adults with
severe a1-antitrypsin deficiency (PiZZ). Thorax 2002;57:705-8
Sandford AJ et al. Genetic risk factors for chronic obstructive pulmonary
disease. Eur Respir J 1997;10:1380-91
Sandford AJ, Silverman
EK. Chronic obstructive pulmonary disease. 1:
Susceptibilty factors for COPD the genotype-environment interaction. Thorax
2002;57:736-41
Schwartz AG,
Ruckdeschel JC. Familial lung cancer. Genetic susceptibility and relationship to
chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:16-22
Shaker SB,
Stavngaard T, Stolk J, Stoel B, Dirksen A. a1-antitrypsin
deficiency 7:computed tomographic imaging in a1-antitrypsin
deficiency. Thorax 2004;59:986-91
Silva GE,
Sherrill DL, Guerra S, Barbee RA. A longitudinal study of a1-antitrypsin phenotypes and decline in FEV1 in a community population. Chest
2003;123:1435-40
Silverman EK,
Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly
JJ, Ginns L, Mentzer S, Wain J, Speizer FE. Genetic epidemiology of severe,
early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow
obstruction and
chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-8
Snider
GL. Facteurs de risque et populations à risque. Rev Mal Respir 1998;15:2S5-2S9
Stockley RA. Alpha-1-antitrypsine deficiency: what next? Thorax 2000;55:614-8
Sunyer J, Pistelli R, Plana E, Andreani M, Baldari F, Kolz M, Koenig W, Pekkanen J, Peters A, Forastiere F. Systemic inflammation, genetic susceptibility and lung function. Eur Respir J 2008;32:92-7
Wang I-M,
Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, Hayashi S, Loy L,
Coulter S, Cervino S, Harris J, Thornton M, Raubertas R, Roberts C,
Hogg JC, Crackower M, O'Neill G, Paré PD. Gene Expression Profiling in
Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer. Am
J Respir Crit Care Med 2008;177:402-11
Wilk JB, DeStefano AL, Arnett DK, Rich SS, Djousse L, Crapo RO, Leppert MF, Province MA, Cupples LA, Gottlieb DJ, Myers RH. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Resp Crit Care Med 2003;167:1528-33
|
recherche
de la cause de cette susceptibilité
45 ans)
Protéases
